Skip to Main Content

Paper Details

Co-clinical Modeling of the Activity of the BET Inhibitor Mivebresib (ABBV-075) in AML.
In Vivo
2
2022
Author NameAffiliation
Neal C GoodwinInc.
Gautam BorthakurThe University of Texas MD Anderson
David A RizzieriNovant Health Cancer Institute
  • 1 - 3

Datasets

Release 1.2